Cristcot Management Company Inc

Cristcot is a global life sciences company headquartered in Massachusetts that specializes in unique drug delivery systems, combination products, and specialty drug formulations. With a focus on unobtrusive care, they measure the performance of their products based on the positive impact they have on the lives of patients and caregivers. Cristcot is renowned for its expertise in expedited regulatory approvals, including 510k and 505(b)(2) pathways. Their target therapies and products are often overlooked by the industry, allowing them to bring much-needed solutions to underserved areas. Committed to ensuring the successful commercial launch of their products, Cristcot utilizes regulatory market exclusivities offered through a 505(b)(2) approval, orphan and new molecular entity designation filings, providing them with 3-7 years of market exclusivity. To further protect their innovations, Cristcot employs a robust patent strategy, securing extended market protection for their technological advancements. They also place a strong emphasis on patents, trademarks, and branding to establish brands with generational longevity. Cristcot's primary therapeutic areas of interest include Gastro